Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?
Why Is Medical Coating Specialist Surmodics Trading Higher On Wednesday?
"We are pleased to announce this transaction, which enables Surmodics shareholders to realize immediate value creation with a substantial premium, reflecting the significant progress and important achievements made by our employees," said Surmodics CEO Gary Maharaj said.Private equity firm GTCR agreed to acquire medical device coating company Surmodics Inc (NASDAQ:SRDX) for approximately $627 million, or $43 per share.
私募股权投资公司GTCR同意以约6.27亿美元，合每股43美元的价格收购医疗器械涂层公司Surmodics Inc（纳斯达克股票代码：SRDX）。
The per-share acquisition price represents a 41.1% premium to Surmodics' 30-trading day volume-weighted average closing price through May 28.
每股收购价格比Surmodics截至5月28日的30个交易日成交量加权平均收盘价高出41.1％。
Surmodics' board unanimously approved the cash deal. It also recommended that stockholders vote in favor of the transaction.
Surmodics董事会一致批准了这笔现金交易。它还建议股东对该交易投赞成票。
"We are pleased to announce this transaction, which enables Surmodics shareholders to realize immediate value creation with a substantial premium, reflecting the significant progress and important achievements made by our employees," said Surmodics CEO Gary Maharaj said.
Surmodics首席执行官加里·马哈拉杰说：“我们很高兴地宣布这项交易，这使Surmodics的股东能够以可观的溢价立即实现价值创造，这反映了我们员工取得的重大进展和重要成就。”
GTCR managing director Sean Cunningham praised Surmodics as "well-positioned for attractive, long-term growth and value creation."
GTCR董事总经理肖恩·坎宁安称赞Surmodics “处于有利地位，可以实现有吸引力的长期增长和价值创造”。
The transaction is expected to close in the second half of 2024.
该交易预计将于2024年下半年完成。
Upon completion of the transaction, Surmodics will be a privately held company, and its common stock will no longer be listed on The Nasdaq Stock Exchange.
交易完成后，Surmodics将是一家私人控股公司，其普通股将不再在纳斯达克证券交易所上市。
Price Action: SRDX shares are up 20.3% at $42.24 at last check Wednesday.
价格走势：周三最后一次检查时，SRDX股价上涨20.3％，至42.24美元。
Now Read: Coinbase Stock Is Trading Lower, What's Going On?
立即阅读：Coinbase股票交易价格走低，发生了什么？